Cure8
The application of an artificial intelligence-enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot study.
Inflammatory bowel diseases

Cure8 research brief

The application of an artificial intelligence-enhanced virtual reality cognitive behavioral therapy tool is feasible and acceptable in patients with inflammatory bowel disease: A multicenter mixed methods pilot study.

2 min read

Why This Matters

IBD patients commonly face anxiety and pain; accessible, scalable digital CBT tools could help fill gaps in mental-health care. This pilot shows AI-enhanced VR CBT is feasible and well accepted and produced immediate reductions in anxiety and pain scores in a small sample.

Who Should Pay Attention

Adults with IBD (including Crohn’s), clinicians treating IBD patients’ mental-health needs, researchers and developers of digital therapeutics and AI/VR interventions.

Study Snapshot

Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract

What To Know

This pilot study tested XAIA, an AI-powered virtual reality application that delivers a single 30-minute CBT-style session to adults with IBD. In 34 participants (median age 34, majority women, 59% Crohn’s), the session was feasible and well accepted; interviews reported feelings of safety, validation, and better coping.

Quantitatively, pain and state anxiety scores improved immediately after the session. The report describes a mixed-methods multicenter pilot—both interviews and before/after measures—so findings are preliminary and focused on acceptability and short-term changes after one session.

If you’re interested in digital mental-health tools, this study suggests an immersive AI-driven VR CBT session can be delivered to IBD patients and may acutely lower pain and anxiety, but it does not establish long-term benefit or replace standard mental-health care.

Keep In Mind

Findings come from a small multicenter mixed-methods pilot with immediate pre/post measures and qualitative interviews. Results are promising but preliminary; the study assesses feasibility and short-term effects after a single session rather than long-term outcomes or randomized efficacy.

Source Details

Review the original publication for the complete reporting, methods, and context.

Read Original Source
Research paper Evidence type derived from source or registry metadata.
PublicationInflammatory bowel diseases
AuthorsAlvin T George, Alexandra R McDermott, Alyse R Bedell +8 more
InstitutionInflammatory Bowel Disease Center, Section of Gastroenterology, Hepatology, and Nutrition, The University of Chicago, Chicago, IL, United States.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedNov 5, 2026, 12:00 AM
Content availableJournal abstract

This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.

Related Reading

Browse latest news →